Assessment of Novel Molecular Markers in Acute Myeloid Leukemia
OBJECTIVES:
- Prospectively obtain specimens required for diagnostic review and molecular
characterization ensuring eligibility for CALGB Leukemia Committee Clinical trials (for
clinical trials designed to enroll specific molecular subtypes, results to determine
eligibility will be reported to treating physicians no more than 72 hours after
specimen receipt at the repository).
- Determine the frequency of specific gene markers (i.e., FLT3 ITD, CBF, MLL PTD, NPM1,
KIT, RAS, CEBPA, WT1, JAK2, RUNX1, TET2, CBL, IDH1 and IDH2, ASXL1, mutations, aberrant
BAALC, ERG, FLT3, MN1, EVI1, and APP) over-expression and levels of promoter
methylation of specific genes (e.g., ESR1, WIT1, P15, MYOD1, ID4, DPK) in defined
cytogenetic subgroups of patients with acute myeloid leukemia (AML).
- Correlate these gene markers with clinical and laboratory parameters in these patients.
- Correlate these gene markers with clinical outcome (i.e., complete remission [CR],
disease-free survival [DFS], cumulative incidence of relapse [CIR], and overall
survival [OS]) in these patients.
- Identify specific microarray multi-gene expression signatures in these patients.
- Correlate specific microarray multi-gene expression signatures with clinical and
laboratory parameters in these patients.
- Correlate specific microarray multi-gene expression signatures with clinical outcome
(i.e., CR, DFS, CIR, and OS) in these patients.
- Identify specific microarray multi-microRNA (miR) expression signatures in these
patients
- Correlate specific microarray multi-miR expression signatures with clinical and
laboratory parameters in these patients.
- Correlate specific microarray multi-miR expression signatures with clinical outcome
(i.e., CR, DFS, CIR, and OS) in these patients.
- Explore the relative contribution of prognostic gene markers (i.e., FLT3 ITD, MLL PTD,
NPM1, KIT, RAS, CEBPA, WT1, and JAK2 mutations, and aberrant BAALC, ERG, FLT3, MN1, and
EVI1 over-expression), levels of promoter methylation of specific genes (e.g., ESR1,
WIT1, P15, MYOD1, ID4, DPK), and microarray gene and miR expression signatures in
defined cytogenetic subgroups of AML.
- Determine changes in these molecular markers and microarray gene and miR expression
signatures at CR and relapse and the influence that these changes have on subsequent
clinical course.
- Correlate the relative level of nuclear pSTAT5 and pERK in bone marrow blasts with
outcome (EFS, CR, DFS, OS).
OUTLINE: This is a multicenter study.
Previously procured and archived bone marrow aspirate samples, blood and buccal cell
samples, and bone marrow biopsy slides are analyzed for FLT3 ITD, MLL PTD, NPM1, KIT, KRAS,
NRAS, CEBPA, WT1, JAK2, RUNX1, TET2, ASXL1, IDH1 and IDH2, and CBL mutations, CBF fusion
genes, levels of BAALC, ERG, EVI1, MN1, and APP microarray gene-expression, microRNA
gene-expression signature, levels of methylation of genes silenced in AML, and genomic DNA
by PCR amplification, RT-PCR, and denaturing high-performance liquid chromatography.
Observational
N/A
Presence of molecular markers that fulfill eligibility criteria in diagnostic samples from AML patients considered for CALGB therapeutic protocols
No
Clara D. Bloomfield, MD
Study Chair
Ohio State University Comprehensive Cancer Center
Unspecified
CDR0000617738
NCT00900224
June 2008
Name | Location |
---|---|
Roswell Park Cancer Institute | Buffalo, New York 14263 |
University of Chicago Cancer Research Center | Chicago, Illinois 60637 |
CCOP - Christiana Care Health Services | Wilmington, Delaware 19899 |
CCOP - North Shore University Hospital | Manhasset, New York 11030 |
CCOP - Illinois Oncology Research Association | Peoria, Illinois 61602 |
Methodist Medical Center of Illinois | Peoria, Illinois 61636 |
Holden Comprehensive Cancer Center at University of Iowa | Iowa City, Iowa 52242-1002 |
CCOP - Grand Rapids | Grand Rapids, Michigan 49503 |
Ellis Fischel Cancer Center at University of Missouri - Columbia | Columbia, Missouri 65203 |
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire 03756-0002 |
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill | Chapel Hill, North Carolina 27599-7570 |
Fletcher Allen Health Care - University Health Center Campus | Burlington, Vermont 05401 |
Long Island Jewish Medical Center | New Hyde Park, New York 11040 |
Florida Hospital Cancer Institute at Florida Hospital Orlando | Orlando, Florida 32803-1273 |
Mount Sinai Medical Center | New York, New York 10029 |
SUNY Upstate Medical University Hospital | Syracuse, New York 13210 |
Presbyterian Cancer Center at Presbyterian Hospital | Charlotte, North Carolina 28233-3549 |
Wake Forest University Comprehensive Cancer Center | Winston-Salem, North Carolina 27157-1096 |
Battle Creek Health System Cancer Care Center | Battle Creek, Michigan 49017 |
Munson Medical Center | Traverse City, Michigan 49684 |
Wayne Memorial Hospital, Incorporated | Goldsboro, North Carolina 27534 |
Greenebaum Cancer Center at University of Maryland Medical Center | Baltimore, Maryland 21201 |
New York Weill Cornell Cancer Center at Cornell University | New York, New York 10021 |
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center | Washington, District of Columbia 20007 |
University of Illinois Cancer Center | Chicago, Illinois 60612-7243 |
CancerCare of Maine at Eastern Maine Medical Center | Bangor, Maine 04401 |
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute | Boston, Massachusetts 02115 |
Butterworth Hospital at Spectrum Health | Grand Rapids, Michigan 49503-2560 |
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis | St. Louis, Missouri 63110 |
Don Monti Comprehensive Cancer Center at North Shore University Hospital | Manhasset, New York 11030 |
Virginia Commonwealth University Massey Cancer Center | Richmond, Virginia 23298-0037 |
St. Joseph Medical Center | Bloomington, Illinois 61701 |
Eureka Community Hospital | Eureka, Illinois 61530 |
BroMenn Regional Medical Center | Normal, Illinois 61761 |
Community Cancer Center | Normal, Illinois 61761 |
Community Hospital of Ottawa | Ottawa, Illinois 61350 |
Oncology Hematology Associates of Central Illinois, PC - Ottawa | Ottawa, Illinois 61350 |
Cancer Treatment Center at Pekin Hospital | Pekin, Illinois 61554 |
Oncology Hematology Associates of Central Illinois, PC - Peoria | Peoria, Illinois 61615 |
OSF St. Francis Medical Center | Peoria, Illinois 61637 |
Proctor Hospital | Peoria, Illinois 61614 |
Illinois Valley Community Hospital | Peru, Illinois 61354 |
Fort Wayne Medical Oncology and Hematology | Fort Wayne, Indiana 46815 |
Mecosta County Medical Center | Big Rapids, Michigan 49307 |
Cancer Institute of New Jersey at Cooper - Voorhees | Voorhees, New Jersey 08043 |
Mountainview Medical | Berlin, Vermont 05602 |
Massachusetts General Hospital | Boston, Massachusetts 02114-2617 |
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital | Pittsburgh, Pennsylvania 15224-1791 |
Tunnell Cancer Center at Beebe Medical Center | Lewes, Delaware 19958 |
Evanston Hospital | Evanston, Illinois 60201-1781 |
Monter Cancer Center of the North Shore-LIJ Health System | Lake Success, New York 11042 |
Leo W. Jenkins Cancer Center at ECU Medical School | Greenville, North Carolina 27834 |
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center | Columbus, Ohio 43210-1240 |
Pardee Memorial Hospital | Hendersonville, North Carolina 28791 |
Harold Alfond Center for Cancer Care | Augusta, Maine 04330 |
Union Hospital of Cecil County | Elkton MD, Maryland 21921 |
Dana-Farber/Brigham and Women's Cancer Center | Boston, Massachusetts 02115 |
Kinston Medical Specialists | Kinston, North Carolina 28501 |
Lacks Cancer Center at Saint Mary's Health Care | Grand Rapids, Michigan 49503 |
Galesburg Clinic, PC | Galesburg, Illinois 61401 |
Illinois CancerCare - Bloomington | Bloomington%, Illinois 61701 |
Illinois CancerCare - Canton | Canton, Illinois 61520 |
Illinois CancerCare - Carthage | Carthage, Illinois 62321 |
Illinois CancerCare - Eureka | Eureka, Illinois 61530 |
Illinois CancerCare - Havana | Havana, Illinois 62644 |
Illinois CancerCare - Kewanee Clinic | Kewanee, Illinois 61443 |
Illinois CancerCare - Macomb | Macomb, Illinois 61455 |
OSF Holy Family Medical Center | Monmouth, Illinois 61462 |
Illinois CancerCare - Monmouth | Monmouth, Illinois 61462 |
Illinois CancerCare - Community Cancer Center | Normal, Illinois 61761 |
Illinois CancerCare - Pekin | Pekin, Illinois 61603 |
Illinois CancerCare - Peru | Peru, Illinois 61354 |
Illinois CancerCare - Princeton | Princeton, Illinois 61356 |
Illinois CancerCare - Spring Valley | Spring Valley, Illinois 61362 |
Mercy General Health Partners | Muskegon, Michigan 49443 |
Camino Medical Group - Treatment Center | Mountain View, California 94040 |
Spectrum Health Reed City Hospital | Reed City, Michigan 49677 |